EUR 3,50
Cantidad disponible: 1 disponibles
Añadir al carritoSoftcover. Condición: Bon. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Good. Ammareal gives back up to 15% of this item's net price to charity organizations.
EUR 12,50
Cantidad disponible: 1 disponibles
Añadir al carritoSoftcover. Condición: Very good.
Idioma: Holandés
Publicado por Uitgeverij Van Gennep, 2023
ISBN 10: 9461645953 ISBN 13: 9789461645951
Librería: Mooney's bookstore, Den Helder, Holanda
EUR 21,38
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Idioma: Holandés
Publicado por Uitgeverij Van Gennep, 2023
ISBN 10: 9461645953 ISBN 13: 9789461645951
Librería: Mooney's bookstore, Den Helder, Holanda
EUR 34,08
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Very good.
Idioma: Inglés
Publicado por Edward Elgar Publishing, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: Books From California, Simi Valley, CA, Estados Unidos de America
EUR 111,06
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good.
Idioma: Inglés
Publicado por Edward Elgar Publishing, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 156,64
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new.
EUR 169,59
Cantidad disponible: 15 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por Edward Elgar Publishing, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 180,92
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Edward Elgar Publishing Ltd, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 171,15
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. 2022. Hardback. . . . . .
Idioma: Inglés
Publicado por Edward Elgar Publishing Ltd, GB, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 194,82
Cantidad disponible: 9 disponibles
Añadir al carritoHardback. Condición: New. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.
EUR 182,22
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 1st edition. 307 pages. 9.50x6.25x1.00 inches. In Stock.
Idioma: Inglés
Publicado por Edward Elgar Publishing Ltd, Cheltenham, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 198,66
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels in the context of current issues and future trends, including those related to COVID-19 and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Idioma: Inglés
Publicado por Edward Elgar Publishing Ltd, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 211,58
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
Idioma: Inglés
Publicado por Edward Elgar Publishing Ltd, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 218,36
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. 2022. Hardback. . . . . . Books ship from the US and Ireland.
Idioma: Inglés
Publicado por Edward Elgar Publishing Ltd, GB, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: Rarewaves.com UK, London, Reino Unido
EUR 184,95
Cantidad disponible: 9 disponibles
Añadir al carritoHardback. Condición: New. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.
Idioma: Inglés
Publicado por Edward Elgar Publishing Ltd, Cheltenham, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 297,57
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels in the context of current issues and future trends, including those related to COVID-19 and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Idioma: Holandés
Publicado por Prometheus, Uitgeverij, 2019
ISBN 10: 9044641344 ISBN 13: 9789044641349
Librería: Buchpark, Trebbin, Alemania
EUR 15,00
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Gut. Zustand: Gut | Sprache: Niederländisch | Produktart: Bücher | Keine Beschreibung verfügbar.
Idioma: Holandés
Publicado por Prometheus, Uitgeverij, 2019
ISBN 10: 9044641344 ISBN 13: 9789044641349
Librería: Buchpark, Trebbin, Alemania
EUR 15,45
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: Hervorragend. Zustand: Hervorragend | Sprache: Niederländisch | Produktart: Bücher | Keine Beschreibung verfügbar.